Table 3.
Changes of AUASS of the SR device group and the active control group during follow-up.
Group A | Group B | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
(M ± SD) | Baseline | 4 wks | 8 wks | 12 wks | P value (post hoc) | Baseline | 4 wks | 8 wks | 12 wks | P value |
Incomplete emptying | 2.30 ± 1.56 | 1.95 ± 1.23 | 1.80 ± 1.44 | 1.70 ± 1.13 | .040* | 1.93 ± 1.44 | 1.60 ± 1.30 | 1.93 ± 1.44 | 1.93 ± 1.28 | .503 |
Frequency | 3.35 ± 1.35 | 2.85 ± 1.42 | 3.05 ± 1.36 | 2.80 ± 1.20 | .057 | 2.20 ± 1.21 | 2.00 ± 1.07 | 1.87 ± 0.74 | 1.80 ± 1.15 | .435 |
Intermittency | 1.40 ± 1.64 | 1.40 ± 1.47 | 1.30 ± 1.34 | 1.15 ± 1.31 | .370 | 1.87 ± 1.25 | 1.53 ± 0.92 | 1.67 ± 1.40 | 1.67 ± 1.18 | .792 |
Urgency | 2.50 ± 1.61 | 1.85 ± 1.46 | 1.75 ± 1.68 | 1.65 ± 1.46 | .046* | 1.47 ± 1.64 | 1.07 ± 0.88 | 1.13 ± 0.99 | 0.93 ± 0.80 | .279 |
Weak stream | 2.70 ± 1.78 | 2.30 ± 1.42 | 1.60 ± 1.35 | 1.50 ± 1.24 | .001** (1 > 3, 4; 2 > 4) | 1.73 ± 1.16 | 1.53 ± 0.92 | 1.60 ± 1.12 | 1.73 ± 1.39 | .868 |
Straining | 0.90 ± 0.97 | 0.45 ± 0.60 | 0.60 ± 0.75 | 0.65 ± 0.93 | .063 | 1.47 ± 1.46 | 1.27 ± 1.10 | 1.27 ± 0.96 | 1.13 ± 0.83 | .589 |
Sleeping | 3.25 ± 1.16 | 2.35 ± 1.18 | 2.25 ± 1.07 | 2.25 ± 1.29 | .001** (1 > 2, 3, 4) | 2.20 ± 0.86 | 2.13 ± 1.13 | 2.13 ± 0.99 | 2.20 ± 1.15 | .977 |
Global score | 16.40 ± 6.27 | 13.15 ± 5.70 | 12.35 ± 6.45 | 11.70 ± 5.91 | <.001*** (1 > 2, 3, 4) | 12.87 ± 6.94 | 11.13 ± 5.17 | 11.60 ± 5.30 | 11.40 ± 5.67 | .513 |